In this undated handout photo from Schering AG, a technician withdraws deep-frozen cells for in-vitro culturing at a laboratory of German pharmaceutical giant Schering. According to news reports March 13 German drug company Merck has launched a 14.6 billion Euros hostile takeover bid for Schering.